Assisted Reproductive Technology (ART) Program Reporting System
Revision of a currently approved collection
No
Regular
Approved without change
03/07/2025
12/20/2024
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
03/31/2028
36 Months From Approved
03/31/2025
416,242
0
308,225
297,352
0
219,904
43,512
0
10,115,670
The Centers for Disease Control and Prevention (CDC) is currently approved to collect information needed to determine the annual pregnancy success rate of each clinic that provides assisted reproductive technology (ART) services (âAssisted Reproductive Technology Program Reporting System,â OMB No. 0920-0556, exp. 7/31/2018). This data collection is required by The Fertility Clinic Success Rate and Certification Act (FCSRCA), Section 2(a) of P.L. 102-493(42 USC 263 (a)-1) which mandates ART clinics to submit information to CDC and requires CDC to publish pregnancy success rates. CDC seeks OMB approval on a revision request to revise burden estimates, modify data elements to align with current clinical practice, and extend information collection for an additional three years. Compared to the burden previously approved, the total annualized burden requested is higher due to an increase in the average number of ART cycles performed per clinic, due to an overall increase in the utilization of ART in the United States.
US Code:
42 USC 301
Name of Law: Public Health Service Act
PL:
Pub.L. 102 - 493 2 (a)
Name of Law: Fertility Clinic Success Rate and Certification Act
CDC revised burden hour estimates and modify data elements collected. Data elements collected will be modified to remove two data elements no longer needed and add one new data element to reflect current clinical practice. CDC will remove the requirement for clinics to report dosage information for long-acting FSH because they are not approved for use in the United States. CDC will remove the requirement for clinics to report the research cycle study type because additional information on research cycle study type is not necessary to report pregnancy success rates. CDC will add the requirement for clinics to report date of fresh embryo cryopreservation for all frozen embryo transfer procedures because it will improve reporting of factors that impact ART success rates. A revised data collection form is provided in Attachment C1. The proposed changes are not anticipated to impact the burden hours to report data for ART cycles.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Form 0920-0556 National ART Surveillance System (NASS) [screen captures]
AttachmentsAtt B2 Response to 60d Comments.pdf
AttachmentsAtt G. Non_Disclosure_Contractors.docx
National ART Surveillance System